ATE404669T1 - In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide - Google Patents

In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide

Info

Publication number
ATE404669T1
ATE404669T1 AT01926595T AT01926595T ATE404669T1 AT E404669 T1 ATE404669 T1 AT E404669T1 AT 01926595 T AT01926595 T AT 01926595T AT 01926595 T AT01926595 T AT 01926595T AT E404669 T1 ATE404669 T1 AT E404669T1
Authority
AT
Austria
Prior art keywords
differentially expressed
breast
bladder cancer
polypeptides encoded
present
Prior art date
Application number
AT01926595T
Other languages
English (en)
Inventor
Maurice Zauderer
Elizabeth Evans
Melinda Borrello
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Application granted granted Critical
Publication of ATE404669T1 publication Critical patent/ATE404669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT01926595T 2000-04-04 2001-04-04 In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide ATE404669T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19446300P 2000-04-04 2000-04-04

Publications (1)

Publication Number Publication Date
ATE404669T1 true ATE404669T1 (de) 2008-08-15

Family

ID=22717696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926595T ATE404669T1 (de) 2000-04-04 2001-04-04 In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide

Country Status (10)

Country Link
US (3) US7268207B2 (de)
EP (1) EP1272636B8 (de)
JP (1) JP2004502408A (de)
CN (2) CN101643732A (de)
AT (1) ATE404669T1 (de)
AU (2) AU5311901A (de)
CA (1) CA2413211A1 (de)
DE (1) DE60135315D1 (de)
NZ (1) NZ522282A (de)
WO (1) WO2001074859A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5311901A (en) * 2000-04-04 2001-10-15 Univ Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
US7135278B1 (en) 2000-09-29 2006-11-14 University Of Rochester Method of screening for therapeutics for infectious diseases
WO2002070003A1 (en) * 2001-02-14 2002-09-12 Genzyme Corporation Altered peptide ligands
US7705120B2 (en) * 2001-06-21 2010-04-27 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
CA2488682C (en) 2002-06-10 2014-04-01 Vaccinex, Inc. Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US9809654B2 (en) 2002-09-27 2017-11-07 Vaccinex, Inc. Targeted CD1d molecules
US20040210037A1 (en) * 2003-03-28 2004-10-21 Vaccinex, Inc. Targeted MHC class I alpha3 vaccine delivery systems
WO2005099361A2 (en) * 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
CN1913921B (zh) * 2003-12-04 2012-02-22 瓦西尼斯公司 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法
US20050266425A1 (en) * 2003-12-31 2005-12-01 Vaccinex, Inc. Methods for producing and identifying multispecific antibodies
JP2007530075A (ja) * 2004-04-23 2007-11-01 エグザジェン ダイアグノスティクス インコーポレイテッド 乳がんの予後診断のための組成物および方法
US20080305111A1 (en) * 2006-06-22 2008-12-11 Vaccinex, Inc. Anti-C35 antibodies for treating cancer
CA2678618C (en) * 2007-02-21 2019-03-12 Vaccinex, Inc. Modulation of nkt cell activity with antigen-loaded cd1d molecules
BRPI0817233A2 (pt) 2007-09-28 2012-11-06 Intrexon Corp construções terapêuticas de gene de trca e bireatores para a expressão de moléculas bioterapêuticas, e usos das mesmas
CN101932333A (zh) 2007-12-26 2010-12-29 瓦西尼斯公司 抗c35抗体联合疗法和方法
JP2012514476A (ja) 2009-01-08 2012-06-28 アルバート アインシュタイン カレッジ オブ メディシン オブ イェシバ ユニバーシティ，ア ディビジョン オブ イェシバ ユニバーシティ 細胞壁結合セラミド様糖脂質による細菌ワクチンおよびその使用
ES2637442T3 (es) * 2009-04-01 2017-10-13 The University Of British Columbia Productos terapéuticos inhibidores de semaforina 3C (SEMA3C), métodos y usos
US8946379B2 (en) 2009-09-24 2015-02-03 The Regents Of The University Of California Bladder cancer specific ligand peptides
US9371352B2 (en) 2013-02-08 2016-06-21 Vaccinex, Inc. Modified glycolipids and methods of making and using the same
EP4299136A3 (de) * 2015-12-16 2024-02-14 Gritstone bio, Inc. Neoantigenidentifizierung, herstellung und verwendung
CN111315390A (zh) * 2017-09-05 2020-06-19 磨石肿瘤生物技术公司 用于t细胞疗法的新抗原鉴别
JP7227237B2 (ja) 2017-10-10 2023-02-21 グリットストーン バイオ インコーポレイテッド ホットスポットを利用した新生抗原の特定
US11885815B2 (en) 2017-11-22 2024-01-30 Gritstone Bio, Inc. Reducing junction epitope presentation for neoantigens
KR102318018B1 (ko) 2019-07-05 2021-10-28 한국생산기술연구원 마이크로 제품 제작용 맨드렐 제작 방법, 마이크로 제품 제작용 몰드 제작 방법 및 마이크로 제품 제작용 몰드

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0581600A (ja) * 1991-04-18 1993-04-02 Fujitsu Ltd 双曲線航法システムにおけるシステム監視処理方式
JP3782100B2 (ja) 1992-08-07 2006-06-07 エピミューン，インコーポレイティド Ｈｌａ結合性ペプチド及びその用途
SG49008A1 (en) 1993-03-05 1998-05-18 Cytel Corp Hla-a2.1 binding peptides and their uses
US5856131A (en) * 1997-02-24 1999-01-05 Incyte Pharmaceuticals, Inc. Human selenoprotein
US7026447B2 (en) * 1997-10-09 2006-04-11 Human Genome Sciences, Inc. 53 human secreted proteins
EP1042360A2 (de) 1997-12-24 2000-10-11 Corixa Corporation Zusammensetzungen für immunotherapie und diagnose von brustkrebs und verfahren für ihre verwendung
WO1999037775A2 (en) * 1998-01-26 1999-07-29 Genquest, Inc. Compositions and methods for detecting and treating breast cancer
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
US20020052308A1 (en) * 1999-03-12 2002-05-02 Rosen Craig A. Nucleic acids, proteins and antibodies
WO2001040269A2 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU5311901A (en) 2000-04-04 2001-10-15 Univ Rochester A gene differentially expressed in breast and bladder cancer and encoded polypeptides
AU5532601A (en) * 2000-04-12 2001-10-30 Univ Rochester Targeted vaccine delivery systems
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
JP4368196B2 (ja) * 2000-11-17 2009-11-18 ユニバーシティー オブ ロチェスター 真核細胞において免疫グロブリン分子を製造および同定するインビトロにおける方法
CA2488682C (en) * 2002-06-10 2014-04-01 Vaccinex, Inc. Gene differentially expressed in breast and bladder cancer and encoded polypeptides
WO2005099361A2 (en) * 2003-07-10 2005-10-27 Vaccinex, Inc. MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
CN1913921B (zh) * 2003-12-04 2012-02-22 瓦西尼斯公司 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法

Also Published As

Publication number Publication date
US20070081942A1 (en) 2007-04-12
WO2001074859A3 (en) 2002-03-28
US7268207B2 (en) 2007-09-11
NZ522282A (en) 2005-03-24
DE60135315D1 (de) 2008-09-25
EP1272636B1 (de) 2008-08-13
CA2413211A1 (en) 2001-10-11
AU5311901A (en) 2001-10-15
US20020155447A1 (en) 2002-10-24
EP1272636A2 (de) 2003-01-08
US7910551B2 (en) 2011-03-22
WO2001074859A2 (en) 2001-10-11
US20090312263A1 (en) 2009-12-17
JP2004502408A (ja) 2004-01-29
CN1610743A (zh) 2005-04-27
AU2001253119B2 (en) 2006-04-13
CN101643732A (zh) 2010-02-10
EP1272636B8 (de) 2008-10-08

Similar Documents

Publication Publication Date Title
ATE404669T1 (de) In brust- und blasenkrebs differentiell exprimiertes gen und durch dieses kodierte polypeptide
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
MXPA03001634A (es) Polipeptido tumoral cripto.
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
HRP20150432T1 (hr) Indentifikacija antigena povezanih s tumorom za dijagnozu i terapiju
WO2001057182A3 (en) Nucleic acids, proteins, and antibodies
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
AR031250A1 (es) Composiciones y metodos para la terapia y el diagnostico del cancer de pulmon
ATE521629T1 (de) Matrixmetalloproteinase-11-impfstoff
EP2070949A3 (de) In Brust- und Blasenkrebs differenziell exprimiertes Gen und kodierte Polypeptide
EA200970607A1 (ru) Универсальная вакцина из опухолевых клеток для противораковой терапии и профилактического использования
WO1999051263A3 (en) Methods and modified cells for the treatment of cancer
TR200101702T2 (tr) Mammaglobin, göğse özgü salgılanan bir göğüs kanseri proteini.
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
MX2021004425A (es) Vacuna contra cancer de cadena invariante de teleosteo.
JP2005524719A5 (de)
ATE206129T1 (de) Herstellung und verwendung des menschlichen nm23- h2-proteins und dagegen gerichtete antikörper
WO2003024302A3 (en) Detection and treatment of cancers of breast
EP1351967A4 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
ATE373711T1 (de) Gewebe-spezifische protein 103p2d6, hochexprimiert in verschiedene krebsarten
IL149045A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO2004078123A3 (en) Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
WO2001098339A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties